Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as
Previous Article
Russell... suruaT rof 'daeha segnellahc'
Next Article
Hummer... ecaR garD A nI XRT maR ,rotpaR